COVID | Norton Healthcare

Indication: COVID

A PHASE 1 STUDY OF AGENT-797 TO TREAT MODERATE TO SEVERE ACUTE RESPIRATORY SYNDROME IN COVID 19 PATIENTS

Sub-indication: COVID-19

Study Type: Drug Study

Principal Investigator: Don Stevens, M.D.
Norton Cancer Institute

Sponsor: Sponsor: Agentus Therapeutics

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.